Aeterna Zentaris to Announce Third Quarter 2016 Financial and Operating Results on November 8, 2016
October 28 2016 - 08:30AM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”)
will announce its third quarter 2016 financial and operating
results after market close on Tuesday, November 8, 2016. The
Company will host a conference call and webcast to discuss these
results on Wednesday, November 9, 2016 at 8:30 a.m. Eastern Time.
During the call, management will also provide an update on the
status and progress related to the Company’s two pivotal phase 3
programs for Macrilen™ and Zoptrex™.
Participants may access the live webcast via the Company's
website at www.aezsinc.com, or by telephone using the following
number: 201-689-8029, Confirmation #13646681. A replay of the
webcast will also be available on the Company’s website for a
period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology, endocrinology and women’s health. We are engaged in drug
development activities and in the promotion of products for others.
We are now conducting Phase 3 studies of two internally developed
compounds: Macrilen™ and Zoptrex™. The focus of our business
development efforts is the acquisition or license of products that
are relevant to our therapeutic areas of focus. We also intend to
license out certain commercial rights of internally developed
products to licensees in territories where such out-licensing would
enable us to ensure development, registration and launch of our
product candidates. Our goal is to become a growth-oriented
specialty biopharmaceutical company by pursuing successful
development and commercialization of our product portfolio,
achieving successful commercial presence and growth, while
consistently delivering value to our shareholders, employees and
the medical providers and patients who will benefit from our
products. For more information, visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161028005078/en/
Aeterna Zentaris Inc.Philip A. Theodore, 843-900-3223Senior Vice
Presidentir@aezsinc.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Mar 2023 to Mar 2024